CJC-1295 without DAC Kit
Price range: $100.00 through $170.00
(CAS 863288-34-0); supplier specifications (); structural comparisons with CJC-1295 with DAC (CAS 446262-90-4).
Description
🧪 Product Profile: CJC-1295 without DAC
Product Name: CJC-1295 without DAC (Modified GRF 1-29)
CAS Number: 863288-34-0
Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: 3367.89 g/mol
Amino Acid Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
Purity: ≥98% (HPLC verified)
Formulation: Lyophilized white powder (standard vials: 5mg, 10mg, or custom specifications)
🔬 Key Characteristics
CJC-1295 without DAC is a synthetic analog of growth hormone-releasing hormone (GHRH), specifically engineered as a modified version of GRF (1-29) with enhanced stability. Unlike its counterpart CJC-1295 with DAC (Drug Affinity Complex), this variant lacks the plasma protein-binding moiety, resulting in a shorter half-life (~30 minutes) and pulsatile growth hormone (GH) secretion profile. Its structure includes D-amino acid substitutions (e.g., D-Ala) to resist enzymatic degradation, ensuring improved bioavailability in preclinical models.
⚙️ Mechanism of Action
- GHRH Receptor Agonism: Binds to GHRH receptors in the anterior pituitary gland, stimulating cyclic AMP (cAMP) signaling and calcium influx to trigger GH release in a dose-dependent manner.
- Pulsatile Secretion: Induces physiological GH pulses similar to endogenous secretion patterns, avoiding desensitization of pituitary somatotrophs compared to continuous GH exposure.
- IGF-1 Mediation: Promotes hepatic synthesis of insulin-like growth factor-1 (IGF-1), the primary mediator of GH’s anabolic effects on muscle, bone, and metabolism.
📊 Research Applications
- Endocrinology: Studies on GH axis regulation, pituitary function, and age-related GH decline models.
- Metabolic Research: Investigation of lean muscle preservation, fat oxidation, and insulin sensitivity in metabolic disorder models.
- Comparative Pharmacology: Contrast studies with CJC-1295 with DAC to evaluate half-life effects on GH/IGF-1 dynamics.
- Peptide Synergy: Combined use with GHRPs (e.g., Ipamorelin) to amplify GH secretion for enhanced anabolic or neuroprotective research outcomes.
💡 Product Features
- Stability: Lyophilized form stable for 24 months at 2-8°C under dry,避光 conditions; reconstitutes in sterile aqueous solvents (e.g., bacteriostatic water).
- Purity: ≥98% HPLC purity with low endotoxin levels (<10 EU/mg), suitable for in vitro and in vivo research.
- Pharmacokinetic Profile: Short-acting nature enables precise control over GH secretion timing in time-course experiments.
⚠️ Disclaimer
For Research Use Only: Not approved for human or veterinary clinical applications. Handling requires adherence to peptide research protocols, including proper reconstitution, storage, and biosafety measures.
Additional information
| FORMAT | 10Bottlex5mg, 10Bottlex10mg |
|---|





